| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 0 | 10.799 | 8.489 | 8.116 |
| Total Income - EUR | - | - | - | - | - | - | 0 | 10.803 | 8.489 | 8.116 |
| Total Expenses - EUR | - | - | - | - | - | - | 713 | 15.850 | 21.123 | 12.856 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -713 | -5.048 | -12.634 | -4.740 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -713 | -5.347 | -12.634 | -4.740 |
| Employees | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Akeso Medfides S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 2.481 | 9.840 | 8.020 |
| Current Assets | - | - | - | - | - | - | 102 | 857 | 144 | 1.091 |
| Inventories | - | - | - | - | - | - | 77 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 0 | 0 | 77 | 63 |
| Cash | - | - | - | - | - | - | 25 | 857 | 67 | 1.028 |
| Shareholders Funds | - | - | - | - | - | - | -673 | -6.022 | -18.638 | -23.274 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 775 | 9.360 | 33.950 | 37.173 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Akeso Medfides S.r.l.